CapsoVision (CV) Share-based Compensation (2024 - 2025)
CapsoVision (CV) posted Share-based Compensation of -$291000.0 for Q3 2025, down 939.29% sequentially from -$28000.0 in Q3 2024, and down 939.29% YoY from $34672.3 in Q3 2024.
CapsoVision (CV) Share-based Compensation (2024 - 2025) Analysis & Trends
CapsoVision has reported Share-based Compensation for 2 years, with the latest figure at -$291000.0 in Q3 2025.
- Quarterly Share-based Compensation fell 939.29% year-over-year to -$291000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$319000.0 (changed N/A YoY) and the FY2025 annual result came in at $31000.0, changed N/A from the prior year.
- Share-based Compensation fell to -$291000.0 in Q3 2025 per CV's latest filing, from -$28000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at -$28000.0 in Q3 2024 and troughed at -$291000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | CapsoVision | 295.13 Mn | 286.05 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 197,000.00 |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | -291,000.00 |
| Sep 30, 2025 | -291,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |